Compare iShares iBoxx $ Inv Grade Corporate Bond ETF (LQD) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares iBoxx $ Inv Grade Corporate Bond ETF vs Recursion Pharmaceuticals Inc — how do they compare? iShares iBoxx $ Inv Grade Corporate Bond ETF trades at $106.78, while Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B). Which is the better fit depends on your goals.
| LQD | RXRX | |
|---|---|---|
52-Week High | $112.91 | $6.79 |
52-Week Low | $106.96 | $2.84 |
Market Cap | — | $1.53B |
Sector | — | Health |
Enterprise Value | — | $946.50M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares iBoxx $ Inv Grade Corporate Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index that the advisor believes will help the fund track the underlying index. The underlying index is designed to provide a broad representation of the US dollar-denominated liquid investment-grade corporate bond market.
Read more on LQD →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
